Chemomab Therapeutics Ltd. (CMMB) NASDAQ
1.74
-0.12(-6.45%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.74
-0.12(-6.45%)
Currency In USD
| Market Cap | 10.52M |
| Enterprise Value | 2.96M |
| P/E Ratio | -1.86 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.3 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.63 |
| Return On Equity | -0.68 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -9.5M |
| Net Income | -8.99M |
| Diluted EPS | -1.42 |
| Total Cash | 8.04M |
| Total Cash/Share | 1.01 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.31 |
| Book Value Per Share | 1.34 |
| 52-Week Change | -67.78 |
| 52-Week High | 5.52 |
| 52-Week Low | 1.35 |
| Moving Average 50 Days | 1.68 |
| Moving Average 200 Days | 2.23 |
| Average Volume | 46,452 |
| Shares Outstanding | 6.16M |
| % Held by Institutions | 4.41 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | August 26, 2025 |